Latest ACTINOGEN MEDICAL (ASX:ACW) News

Page 3

Page 3 of 3

Actinogen Accelerates Alzheimer's Trial with $22.9M Cash Boost

Actinogen Advances Alzheimer's Trial with $22.9M Cash Boost

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.

Ada Torres

29 Jan 2025